D-0817-2020 Class II Terminated
FDA drug recall D-0817-2020 was initiated by MPRX, Inc. dba Medical Park Pharmacy on December 18, 2019 and is designated Class II. Reason for recall: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components. The recall status is terminated (terminated December 13, 2022). Affected quantity: 2 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- February 5, 2020
- Initiation Date
- December 18, 2019
- Termination Date
- December 13, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2 bottles
Product Description
T3/T4 SR 9 mcg/38 mcg capsule
Reason for Recall
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Distribution Pattern
TX
Code Information
Lot: 61296:42Use by: 04/13/2020